Cyclic nucleotide signaling and drug discovery
Submission Deadline: 31 Dec 2009
Guest Editor
Keywords
- Cancer
- Cell Biology
- Molecular Biology
- Signaling
- Therapeutics
Published Papers (5)
The inflammatory network: bridging senescent stroma and epithelial tumorigenesis
Front. Biosci. (Landmark Ed) 2009, 14(11), 4044–4057; https://doi.org/10.2741/3511
(This article belongs to the Special Issue Cyclic nucleotide signaling and drug discovery)
Chemical genetic screening of KRAS-based synthetic lethal inhibitors for pancreatic cancer
Front. Biosci. (Landmark Ed) 2009, 14(8), 2904–2910; https://doi.org/10.2741/3421
(This article belongs to the Special Issue Cyclic nucleotide signaling and drug discovery)
Ovarian cancer: pathology, biology, and disease models
Front. Biosci. (Landmark Ed) 2009, 14(6), 2089–2102; https://doi.org/10.2741/3364
(This article belongs to the Special Issue Cyclic nucleotide signaling and drug discovery)
Oncogenic transformation and experimental models of human cancer
Front. Biosci. (Landmark Ed) 2008, 13(1), 71–84; https://doi.org/10.2741/2661
(This article belongs to the Special Issue Cyclic nucleotide signaling and drug discovery)
Proteomics analyses of ovarian caner using genetically defined human ovarian cancer models
Proteomics analyses of ovarian caner using genetically defined human ovarian cancer models
Front. Biosci. (Landmark Ed) 2007, 12(13), 5166–5174; https://doi.org/10.2741/2556
(This article belongs to the Special Issue Cyclic nucleotide signaling and drug discovery)